| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.038 | 0.8 |